| P/E (FY) | — | Sales (TTM) | €7.9M |
| Earnings (TTM) | -€12.8M | ROE | — |
| Net Margin | −161.06% | ROIC | −133.67% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally for gastroenterology, pulmonology, and urology applications. Its portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that lets doctors visualize cells, monitor disease over time, guide surgical interventions, and support diagnosis and treatment. The company was incorporated in 2000 and is headquartered in Paris, France.
No price history for ALMKT.PA — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for ALMKT.PA, so risk analytics are unavailable.
No same-industry peers in the universe for ALMKT.PA.
